Examkin

Question

Difficulty: MediumGynecologic Infections

During a visit to the urgent care clinic, a 21-year-old college student describes experiencing deep, aching lower pelvic pain that has progressively worsened over the past three days. She also reports noticing blood on her toilet tissue between her regular menstrual cycles. She has had two new sexual partners in the last six months and uses oral contraceptives inconsistently. Her vital signs show a temperature of 38.3°C (100.9°F), a heart rate of 98/min, and a blood pressure of 112/72 mm Hg. Palpation of the lower abdomen elicits tenderness without guarding. A speculum examination reveals a friable cervix with thick, yellow exudate at the os. During the bimanual exam, the patient vocalizes significant pain when the cervix is mobilized laterally, and both adnexa are tender to palpation, though no discrete masses are felt. A point-of-care pregnancy test is negative. In addition to obtaining samples for nucleic acid amplification testing, which of the following is the most appropriate next step in the management of this patient?

  1. Initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazoleAnswer
  2. B
    Initiate outpatient therapy with intramuscular ceftriaxone and oral azithromycin
  3. C
    Admit to the hospital for intravenous cefotetan and intravenous doxycycline
  4. D
    Obtain a transvaginal ultrasound prior to initiating antimicrobial therapy
  5. E
    Withhold antimicrobial therapy until the results of the diagnostic tests are available

Answer

Initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole
The correct response is to initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. This patient's presentation of lower pelvic pain, fever, mucopurulent cervicitis, cervical motion tenderness, and adnexal tenderness is highly diagnostic for acute pelvic inflammatory disease (PID). Because PID can cause permanent tubal scarring leading to infertility or ectopic pregnancy, empiric broad-spectrum antibiotic therapy must be started immediately upon clinical suspicion. The Centers for Disease Control and Prevention (CDC) recommends an outpatient regimen consisting of a single dose of intramuscular ceftriaxone plus a 14-day course of oral doxycycline and oral metronidazole to adequately cover N. gonorrhoeae, C. trachomatis, and anaerobic vaginal flora.

Step-by-Step Solution

1
Analyze the patient's presentation and physical examination findings.
The patient has acute lower abdominal pain, intermenstrual bleeding, fever, mucopurulent cervicitis, cervical motion tenderness, and bilateral adnexal tenderness without a palpable mass.
Identifying the constellation of symptoms and signs is necessary to establish a clinical diagnosis.
2
Determine the clinical diagnosis based on established criteria.
The combination of pelvic pain, cervical motion tenderness, adnexal tenderness, and fever in a sexually active young woman strongly supports a clinical diagnosis of acute Pelvic Inflammatory Disease (PID).
PID is a clinical diagnosis; awaiting laboratory confirmation delays necessary treatment and increases the risk of complications.
3
Determine the appropriate setting and regimen for management.
The patient does not meet criteria for hospitalization (e.g., severe illness, pregnancy, tubo-ovarian abscess). Outpatient empiric therapy with IM ceftriaxone, PO doxycycline, and PO metronidazole should be initiated immediately.
Standard outpatient PID guidelines require comprehensive coverage for N. gonorrhoeae, C. trachomatis, and anaerobes.

Key Concept

Patients with a clinical diagnosis of mild-to-moderate pelvic inflammatory disease should immediately receive empiric outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole to prevent long-term reproductive complications.
Estimated Time:1m 15s
Rate this question

Topics

Gynecologic Infections

More questions from this topic